Biopharmaceutical companies are currently faced with the challenge of ballooning costs during the drug discovery process. Overhead expenses and rising inflation are just some of the factors that add to the overall cost of discovering new therapies. As a result, biopharmaceutical companies are looking for new ways to both lower costs and increase efficiency. It’s no wonder, then, that they’ve enthusiastically adopted automation software.
Automation lowers the costs of drug discovery, but not necessarily by being faster than human effort/teams. The strength of process automation lies in the ability to work without stopping. While a human will need to take a break eventually, a well-maintained automation system can work day-in and day-out.
This is not to say that getting rid of human workers altogether is the best way to improve the drug discovery process. This is where a collaborative approach to process automation software is realistically employed in the biopharmaceutical industry.
Whether it boils down to systems working alongside or without humans, automation software is necessary in order to establish a safe and efficient environment in laboratories. Bringing process automation software into the fold not only makes things safer, but allows the drug discovery process to incorporate the strengths that both robots and humans can bring to the table. Technology only reaches its maximum effectiveness when the necessary systems are in place to support it.
Drug discovery encompasses many points of data that need to be taken into account throughout the process. While humans, especially those with experience in the industry, are able to take many of these data points into consideration during the decision-making process, their capacity to do so is much more limited when compared to automation.
This is where the process automation software comes into play. This type of software can track many processes that are happening at the same time, allowing for multiple steps in the drug discovery process to happen concurrently, all while minimizing potential errors.
Genera 6, the latest version of Retisoft’s automation scheduling software, can make the drug discovery process more efficient and more cost-effective. Retisoft took feedback from clients regarding previous versions, and has completely redesigned the interface, making the user experience one that is smoother than ever. Contact us to find out how we can provide sophisticated solutions to the drug discovery process.